Ted Bosworth
Combination Therapy Boosts Durability of CAR T-Cell Response in Hematologic Cancers
In hematologic malignancies, chimeric antigen receptor (CAR)-modified T cells will be increasingly combined with ...
JANUARY 10, 2019
PGx Test May Spare Breast Cancer Chemotherapy
Women with HR-positive, HER2-negative breast cancer who are at a midrange risk by genomic scoring can forgo ...
JANUARY 8, 2019
Registry Analysis Sees No Effect of Aspirin for IBD
Vienna—Daily use of aspirin has no effect—good or bad—on outcomes in inflammatory bowel disease, ...
AUGUST 10, 2018
Preserving Checkpoint Inhibitor Benefits
Denver—For the minority of patients who develop significant immune-related adverse events (AEs) while taking ...
JULY 7, 2018
Mitigating Fungal Infection Risk in Blood Cancers
Denver—Many good strategies for prophylaxis and treatment of invasive fungal infections (IFI) in cancer ...
JULY 7, 2018
Checkpoint Inhibitor AEs Checked With Steroids
To manage the immune-related adverse events of checkpoint inhibitors—particularly those caused by ...
MAY 18, 2018
Azithromycin Appears Worthy Stand-in For Erythromycin in Upper GI Bleeding
IV azithromycin is a viable substitute for erythromycin to cleanse the visual field during endoscopic treatment of ...
MARCH 26, 2018
Large Study Confirms DAAs Protect Against HCC When SVR Achieved
Patients with hepatitis C who are successfully treated with direct-acting antiviral agents experience a dramatic ...
MARCH 1, 2018
Genomic Tool Cuts Chemo in Early Breast Cancer
New Orleans—A genomic assay can help determine whether adjuvant therapy is needed in patients who have ...
AUGUST 10, 2016
Digital Medicine Scores a Victory In Lung Cancer
Using an app to monitor symptoms, lung cancer patients achieved a highly significant improvement in overall ...
JULY 6, 2016
